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ABSTRACT
Objective: To synthesise the available evidence and
estimate the comparative efficacy of control strategies to
prevent total hip replacement (THR)-related surgical site
infections (SSIs) using a mixed treatment comparison.
Design: Systematic review and mixed treatment
comparison.
Setting: Hospital and other healthcare settings.
Participants: Patients undergoing THR.
Primary and secondary outcome measures:
The number of THR-related SSIs occurring following
the surgical operation.
Results: 12 studies involving 123 788 THRs and 9
infection control strategies were identified. The strategy
of ‘systemic antibiotics+antibiotic-impregnated cement
+conventional ventilation’ significantly reduced the risk
of THR-related SSI compared with the referent strategy
(no systemic antibiotics+plain cement+conventional
ventilation), OR 0.13 (95% credible interval (CrI) 0.03–
0.35), and had the highest probability (47–64%) and
highest median rank of being the most effective
strategy. There was some evidence to suggest that
‘systemic antibiotics+antibiotic-impregnated cement
+laminar airflow’ could potentially increase infection risk
compared with ‘systemic antibiotics+antibiotic-
impregnated cement+conventional ventilation’, 1.96
(95% CrI 0.52–5.37). There was no high-quality
evidence that antibiotic-impregnated cement without
systemic antibiotic prophylaxis was effective in reducing
infection compared with plain cement with systemic
antibiotics, 1.28 (95% CrI 0.38–3.38).
Conclusions: We found no convincing evidence in
favour of the use of laminar airflow over conventional
ventilation for prevention of THR-related SSIs, yet laminar
airflow is costly and widely used. Antibiotic-impregnated
cement without systemic antibiotics may not be effective
in reducing THR-related SSIs. The combination with the
highest confidence for reducing SSIs was ‘systemic
antibiotics+antibiotic-impregnated cement+conventional
ventilation’. Our evidence synthesis underscores the need
to review current guidelines based on the available
evidence, and to conduct further high-quality double-
blind randomised controlled trials to better inform the
current clinical guidelines and practice for prevention of
THR-related SSIs.
INTRODUCTION
Despite numerous advances in hip arthro-
plasty, surgical site infection (SSI) following
total hip replacement (THR) remains a
serious threat. Infection causes functional
impairment, reduces quality of life and creates
large costs for patients and the healthcare
system. Identifying evidence based and effect-
ive infection control strategies to prevent
THR-related SSI is critically important.
Evidence for the effectiveness of infection
control measures in reducing THR-related SSI
has been inconsistent.1–3 Previous evidence
syntheses focused on single infection control
measures such as systemic antibiotic prophy-
laxis,4 5 antibiotic-impregnated cement6 7 or
ventilation systems alone8 without examining
the combined effect of multiple control mea-
sures. In practice, infection control strategies
combine multiple infection control measures,
yet no good evidence is available on the com-
bined comparative effectiveness of strategies
involving multiple measures.
Strengths and limitations of this study
▪ This study is the first to examine the comparative
effectiveness of various infection control strat-
egies involving multiple infection control mea-
sures in preventing THR-related SSIs. Multiple
sensitivity analyses contributed to the methodo-
logical rigour of the study.
▪ The small number of studies available for evi-
dence synthesis reduced the statistical power
and resulted in wide credible intervals for some
comparisons.
▪ Owing to limited data available, the MTC model
was unable to adjust for potential confounders
such as casemix, different types of laminar
airflow systems and temporal changes in clinical
practices and infection control technology which
may have taken place over the past several
decades.
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Previous evidence syntheses relied on narrative system-
atic reviews or conventional pairwise meta-analysis. These
do not compare the effectiveness of all trialled control
measures when the evidence base of published studies
does not include all possible comparisons.9 The remedy is
to deﬁne a connected network of the evidence base and
combine all the available data in a single mixed treatment
comparison (MTC) model.9 10 This enables comparisons
of all available infection control strategies to better inform
decision making.
We conducted a MTC, also known as network
meta-analysis, to synthesise the available evidence and
determine the combined comparative effectiveness of
infection control strategies in preventing THR-related
SSI in patients undergoing THR.
METHODS
We applied the Patient, Intervention, Comparison and
Outcome (PICO) framework. The population of interest
was patients undergoing THR. The interventions were
infection control strategies to prevent THR-related SSI.
The comparison was an intervention strategy that was
compared with the other intervention strategies in the
MTC network. The outcome of interest was the number
of THR-related SSIs. The PICO framework was speciﬁed
in box 1.
Study identification
We chose antibiotic prophylaxis, antibiotic-impregnated
cement and laminar airﬂow based on published guide-
lines and a survey of expert opinion.11 We followed the
systematic review guidelines in the PRISMA statement.12
We used a two-stage search strategy. First, we used system-
atic reviews by Glenny and Song4 and AlBuhairan et al5 to
locate studies on the efﬁcacy of systemic antibiotic
prophylaxis in preventing THR-related infection.
Together, these covered the years from 1966 to 2007.
Systematic reviews by Parvizi et al6 and Block and Stubbs7
were used to locate trials on the effect of antibiotic-
impregnated cement in preventing THR-related SSI.
These reviews covered the years from 1966 to 2004. We
used the recent systematic review by Whitehead et al8 to
locate studies on the efﬁcacy of operating theatre ventila-
tion systems in preventing THR-related SSI, which
covered the years from 1970 to 2007.
Second, we updated these systematic reviews by
extending the search periods to June 2011. The elec-
tronic databases searched were MEDLINE, EMBASE,
CINAHL and the Cochrane Central Register of
Controlled Trials. Relevant journals, conference pro-
ceedings and bibliographies of retrieved papers were
searched. Eleven orthopaedic surgeons and infection
control experts from six hospitals were consulted. The
search was limited to English-language papers (the
search details are in online supplementary appendix 1).
Studies were included if they reported THR-related
deep SSI or infection requiring a joint revision proced-
ure as an outcome. While the precise deﬁnitions varied,
they encompassed signs of infection involving the joint
and/or fascial tissue at the site of the joint. Owing to
the limited number of studies available, we included
observational studies as well as randomised controlled
trials (RCTs).
Studies were excluded if THR-related SSIs were not
separated from knee or other joint replacement-related
infections. Studies that only compared different types,
doses or durations of antibiotic regimens were treated as
one-arm trials and excluded from the network
meta-analysis as MTC relies on there being at least two
arms that can become part of the network.10 The anti-
biotics were combined because there is little evidence of
different efﬁcacies in preventing THR-related SSI
between antibiotics according to their type, dose or dur-
ation.4 The two-stage search process is in the ﬂow chart
(ﬁgure 1; reasons for exclusion are shown in online sup-
plementary appendix 2).
Data extraction
Data were extracted by two independent reviewers and
discrepancies were resolved by consensus. The key data
were the number of THRs performed and THR-related
deep SSIs; use of antibiotic prophylaxis and its delivery
mode; and operating theatre ventilation system.
Quality assessment
The quality of the included studies and their level of evi-
dence were assessed based on the National Institute for
Health and Care Excellence (NICE) public health
guidelines13 (see online supplementary appendix 3),
and quality scoring systems for RCTs by the Joanna
Briggs Institute14 and observational longitudinal studies
by Tooth et al15 (see online supplementary appendix 4).
Statistical methods
MTC models produce estimates of the relative effects of
each infection control strategy compared with every
other strategy in a network, thus allowing coherent jud-
gements to be made on which strategy is the most effect-
ive.9 It enables simultaneous comparisons of multiple
infection control strategies from trials that did not neces-
sarily directly compare all strategies.9 10 Bayesian
methods have been developed for MTC models (see
online supplementary appendix 5).16
Box 1 Patient, Intervention, Comparison and Outcome
framework
Population: Patients undergoing total hip replacement.
Intervention: Infection control strategies to prevent total hip
replacement (THR)-related surgical site infection (SSI).
Comparison: An infection control strategy compared with other
control strategies in the mixed treatment comparison network.
Outcome: The number of THR-related SSIs.
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The MTC analysis was performed using a binomial
random effect model allowing multiarm trials.17 The key
summary statistics were the relative infection control
effects using ORs, and the probability and median rank
of being the most effective strategy. Studies with longer
follow-up periods were likely to ﬁnd more infections;
hence, we accounted for this by modelling the duration
of follow-up (see online supplementary appendix 6).
The models were ﬁtted in a Bayesian framework using
the WinBUGS program and code by Dias et al.17
Evaluation of model fit and evidence consistency
We assessed the models’ goodness of ﬁt (see online sup-
plementary appendix 7). Where the model ﬁt was poor,
we explored the inﬂuence of each study on the model
ﬁt (see online supplementary appendix 8).
An assumption of MTC models is that direct and indir-
ect sources of evidence estimate the same true treatment
effect across the network. We checked this assumption
by conventional pairwise meta-analyses and by removing
the constraint that direct and indirect evidence estimate
the same effect.18 The latter is also known as node-
splitting (see online supplementary appendix 9).
Heterogeneity and sensitivity analysis
Heterogeneity of the MTC network was quantiﬁed by
using the between-study SD. We performed sensitivity
analyses by removing outliers as identiﬁed through diag-
nostic assessment.
There may have been a difference in evidence
between RCTs and observational studies. To examine
this, we performed a meta-regression with study type as
an interaction (see online supplementary appendix
10).19 In further sensitivity analyses, we excluded the
RCT by Hill et al20 due to its reported violation of the
RCT trial code, and included the RCT by Lidwell et al1
which was initially excluded because it did not separate
THRs from knee replacements.
RESULTS
The two-stage search strategy yielded 529 studies, of
which 12 met our inclusion criteria. Six were RCTs20–25
and six were observational studies.2 3 26–29 The studies
included 123 788 THRs and 9 infection control strat-
egies as mapped in the MTC network (ﬁgure 2). The
raw data are in the Summary of Evidence (table 1).
The quality of evidence was mixed with the level of
evidence ranging from 1 to 2 (table 1).
Five of six studies21–25 provided no information on
random sequence generation; four22–25 provided no
information on blinding assessors; and only one
reported prior calculation of the sample size.20 The stat-
istical power for most RCTs was generally low. Only one
Figure 1 Two-stage literature search flow chart.
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RCT reported primary analysis based on all randomised
cases20 while the rest did not report intention to treat.
Of the six observational studies, three3 28 29 identiﬁed
and adjusted for confounding variables. One26 reported
that cases and control groups were comparable on diag-
nostic confounding factors, and two28 29 described and
included in the analysis the outcomes of the patients who
withdrew. Four studies2 3 28 29 used objective measures to
assess the outcomes, and were adequately powered with
large sample size ranging from 10 905 to 51 485.
For every infection control strategy in the connected
network, a relative effect was estimated against another
infection control strategy using the OR. We chose ‘no
systemic antibiotics, plain cement and conventional ven-
tilation’ as the referent strategy, as it was compared with
the greatest number of other strategies.
Thirty-six relative effects involving nine infection
control strategies were estimated in the MTC network
using models that did and did not adjust for duration of
follow-up (see online supplementary appendix 11 and
table 2). The results from both models were almost iden-
tical, as were estimates of the model ﬁt. Hence, the dif-
ferences in follow-up duration had little effect on the
effectiveness of the infection strategies. We therefore
report the results of the model without adjustment for
follow-up from now on (table 2). The 36 ORs for all
pairwise comparisons are in the Forest Plot (ﬁgure 3).
The ﬁve infection control strategies associated with a
statistically signiﬁcant reduction in THR-related SSI com-
pared with the referent strategy T1 were: T6 (systemic
antibiotics+antibiotic-impregnated cement+conventional
ventilation), OR 0.13 (95% credible interval (CrI) 0.03–
0.35); T2 (systemic antibiotics+plain cement+conventional
ventilation), 0.31 (0.12–0.65); T3 (no systemic antibiotics
+plain cement+laminar airﬂow), 0.26 (0.03–0.95); T4 (sys-
temic antibiotics+plain cement+laminar airﬂow), 0.25
(0.06–0.66); and T7 (systemic antibiotics+antibiotic-
impregnated cement+laminar airﬂow), 0.27 (0.03–0.93;
table 3).
Statistically non-signiﬁcant reductions in THR-related
SSIs as compared with the referent were T5 (no systemic
antibiotics+antibiotic-impregnated cement+conventional
ventilation), OR 0.38 (95% CrI 0.09–1.12); T8 (systemic
antibiotics+antibiotic-impregnated cement+conventional
ventilation+body exhaust suit), 0.52 (0.03–2.12) and T9
(systemic antibiotics+antibiotic-impregnated cement+
laminar ventilation+body exhaust suit), 0.74 (0.05–2.69).
The OR for T7 (systemic antibiotics+ antibiotic-
impregnated cement+laminar airﬂow) compared with
T6 (systemic antibiotics+antibiotic-impregnated cement
+conventional ventilation) was 1.96 (95% CrI 0.52–5.37),
suggesting that laminar airﬂow could potentially
increase infection risk.
There was no high-quality evidence that antibiotic-
impregnated cement without systemic antibiotics was
effective in reducing infection compared with plain
cement with systemic antibiotics (T2 vs T5), 1.28 (95%
CrI 0.38–3.38).
Strategy T6 had the highest probability and highest
median rank of being the best strategy in reducing
THR-related SSI (see online supplementary appendix 12).
Model fit and evidence consistency
The model ﬁt statistics indicated that the ﬁt was less
than adequate (table 2). This was conﬁrmed by diagnos-
tic plots, which showed that infection control strategies
Figure 2 The mixed treatment comparison network consisting of 12 studies with 9 infection control strategies.
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Table 1 Summary of evidence: comparisons of nine control strategies across the MTC network
Author/year/study
design/country Comparison of infection control strategies
Infection
control
strategy
Number of
THR-related
SSIs
Number
of THRs
Evidence level and quality
assessment
Study
number
Carlsson et al (1977)21
RCT, Sweden
Schulitz et al (1980)22
RCT, Germany
The referent strategy T1 (no systemic antibiotics
+plain cement+conventional ventilation) vs T2
(systemic antibiotics+plain cement+conventional
ventilation)
T1
T2
7
0
58
60
Evidence level: 1- 1
C1 C2 C3 C4 C5 C6 C7 C8
1 2 2 1 1 1 3 3
T1
T2
8
1
89
105
Evidence level: 1- 2
C1 C2 C3 C4 C5 C6 C7 C8
1 1 1 1 2 2 3 2
Salvati et al (1982)26
Observational study,
Italy
Fitzgerald (1992)23
RCT, USA
Kelly et al (1996)27
Observational Study,
UK
T2 (systemic antibiotics+plain cement
+conventional ventilation) vs T4 (systemic
antibiotics+plain cement+laminar airflow)
T2
T4
11
13
761
1518
Evidence level: 2- 5
C1 C2 C3 C4 C5 C6 C7 C8
1 2 3 2 1 2 1 3
T2
T4
4
1
1739
1682
Evidence level: 1- 7
C1 C2 C3 C4 C5 C6 C7 C8
1 2 1 1 1 1 1 2
T2
T4
0
3
236
207
Evidence level: 2- 8
C1 C2 C3 C4 C5 C6 C7 C8
1 1 1 1 1 3 1 2
Josefsson et al
(1981)24
RCT, Sweden
McQueen et al (1990)25
RCT, UK
T2 (systemic antibiotics+plain cement
+conventional ventilation) vs T5 (no systemic
antibiotics+antibiotic-impregnated cement
+conventional ventilation)
T2
T5
10
2
812
821
Evidence level: 1- 4
C1 C2 C3 C4 C5 C6 C7 C8
1 2 1 1 1 1 3 3
T2
T5
1
2
190
190
Evidence level: 1- 6
C1 C2 C3 C4 C5 C6 C7 C8
1 2 1 1 1 2 3 3
Brandt et al (2008)3
Observational study,
Germany
T6 (systemic antibiotics+antibiotic-impregnated
cement+conventional ventilation) vs T7
(systemic antibiotics+antibiotic-impregnated
cement+laminar airflow)
T6
T7
99
242
10 966
17 657
Evidence level: 2+ 11
C1 C2 C3 C4 C5 C6 C7 C8
2 3 1 3 2 2 2 3
Hill et al (1981)20
RCT, France
The referent strategy T1 (no systemic antibiotics
+plain cement+conventional ventilation) vs T2
(systemic antibiotics+plain cement+conventional
ventilation) vs T3 (no systemic antibiotics+plain
cement+laminar airflow) vs T4 (systemic
antibiotics+plain cement+laminar airflow)
T1
T2
T3
T4
31
4
4
6
596
590
471
480
Evidence level: 1- 3
C1 C2 C3 C4 C5 C6 C7 C8
2 2 2 2 2 3 2 3
Continued
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Table 1 Continued
Author/year/study
design/country Comparison of infection control strategies
Infection
control
strategy
Number of
THR-related
SSIs
Number
of THRs
Evidence level and quality
assessment
Study
number
Espehaug et al
(1997)28
Observational study,
Norway
The referent strategy T1 (no systemic antibiotics
+plain cement+conventional ventilation) vs T2
(systemic antibiotics+plain cement+conventional
ventilation) vs T5 (no systemic antibiotics
+antibiotic-impregnated cement+conventional
ventilation) vs T6 (systemic antibiotics
+antibiotic-impregnated cement+conventional
ventilation)
T1
T2
T5
T6
3
25
3
8
276
4586
239
5804
Evidence level: 2+ 9
C1 C2 C3 C4 C5 C6 C7 C8
2 3 2 3 2 3 3 3
Engesaeter et al
(2003)29
Observational study,
Norway
T1
T2
T5
T6
3
46
3
50
280
5960
254
15 676
Evidence level: 2+ 10
C1 C2 C3 C4 C5 C6 C7 C8
2 3 2 3 2 3 3 3
Hooper et al (2011)2
Observational study,
New Zealand
T6 (systemic antibiotics+antibiotic-impregnated
cement+conventional ventilation) vs T7
(systemic antibiotics+antibiotic-impregnated
cement+laminar airflow) vs T8 (systemic
antibiotics+antibiotic-impregnated cement
+conventional ventilation+body exhaust suit) vs
T9 (systemic antibiotics+antibiotic-impregnated
cement+laminar ventilation+body exhaust suit)
T6
T7
T8
T9
17
9
4
16
31 939
8772
2696
8078
Evidence level: 2+ 12
C1 C2 C3 C4 C5 C6 C7 C8
2 2 2 3 1 3 2 3
Note: ‘C’ denotes the quality assessment criterion as specified in online supplementary appendix 4.
RCT, randomised controlled trial; SSI, surgical site infection; THR, total hip replacement.
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Table 2 ORs with 95% credible intervals of all nine infection control strategies based on the logit link random effect MTC model
Comparison of infection
control strategies OR and 95% credible interval
OR (1,2)
0.31 (0.12–0.65)
OR (1,3)
0.26 (0.03–0.95)
OR (2,3)
0.92 (0.11–3.39)
OR (1,4)
0.25 (0.06–0.66)
OR (2,4)
0.84 (0.28–1.97)
OR (3,4)
1.93 (0.20–7.58)
OR (1,5)
0.38 (0.09–1.12)
OR (2,5)
1.28 (0.38–3.38)
OR (3,5)
3.28 (0.27–14.15)
OR (4,5)
1.96 (0.37–6.54)
OR (1,6)
0.13 (0.03–0.35)
OR (2,6)
0.44 (0.13–1.13)
OR (3,6)
1.12 (0.09–4.62)
OR (4,6)
0.67 (0.12–2.12)
OR (5,6)
0.43 (0.09–1.24)
OR (1,7)
0.27 (0.03 to 0.93)
OR (2,7)
0.90 (0.13–3.14)
OR (3,7)
2.47 (0.11–10.22)
OR (4,7)
1.41 (0.14–5.35)
OR (5,7)
0.88 (0.09–3.10)
OR (6,7)
1.96 (0.52–5.37)
OR (1,8)
0.52 (0.03–2.12)
OR (2,8)
1.77 (0.11–7.20)
OR (3,8)
5.78 (0.10–21.12)
OR (4,8)
2.89 (0.12–11.73)
OR (5,8)
1.71 (0.08–6.93)
OR(6,8)
3.72 (0.38–13.75)
OR (7,8)
2.26 (0.22–8.48)
OR (1,9)
0.74 (0.05–2.69)
OR (2,9)
2.49 (0.20–9.11)
OR(3,9)
13.15 (0.18–27.4)
OR(4,9)
4.11 (0.22–14.92)
OR (5,9)
2.44 (0.15–8.62)
OR(6,9)
5.00 (0.73–16.87)
OR (7,9)
3.14 (0.42–10.41)
OR (8,9)
2.53 (0.23–10.41)
Model fit statistic (posterior mean residual deviance) 34.3* Model fit statistic (DIC) 180.6 Heterogeneity (between-study deviation) 0.63
*Compared with 32 data points (model fit is considered to be adequate if the posterior mean residual deviance is approximately equal to the number of total data points; see online
supplementary appendix 6 for reference).
DIC, deviance information criterion; MTC, mixed treatment comparison.
Zheng
H,BarnettAG,M
erolliniK,etal.BM
J
Open
2014;4:e003978.doi:10.1136/bm
jopen-2013-003978
7
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 June 2, 2015 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
T2 and T5 of study 4 and the referent strategy of study
10 were outliers contributing to the inadequate model
ﬁt (see online supplementary appendix 13). After exclu-
sion of these two studies, the model ﬁtted the data well,
as indicated by model ﬁt statistics, and the heterogeneity
was signiﬁcantly reduced, but the results were little
changed (see online supplementary appendix 14).
Infection control strategy T6 remained dominant with
the highest probability (64%) and highest median rank
of being the most effective strategy (see online supple-
mentary appendix 15), and OR 0.09 (95% CrI 0.02–
0.25; see online supplementary appendix 14).
The direct evidence from all conventional pairwise
meta-analyses was presented in online supplementary
appendix 16. There was broad agreement among the
direct evidence from: conventional pairwise
meta-analyses, the direct and indirect evidence from
node splitting, and the evidence from the MTC model
(see online supplementary appendix 16). Tests for
inconsistency between direct and indirect evidence from
node splitting suggested that there was no statistically sig-
niﬁcant evidence of inconsistency. The model ﬁt statis-
tics for the node-splitting and the MTC models were
similar, implying that there was no conﬂict between the
direct and indirect evidence (see online supplementary
appendix 16). It is worth noting that the 95% CrIs for
some pairwise comparisons widened greatly following
node splitting. This is explained by the node splitting
reducing the evidence available to inform the variance.
A test of interaction between RCTs and observational
studies was not statistically signiﬁcant, suggesting that
combining these study types was not inappropriate (see
online supplementary appendix 17).
The results were little changed by excluding the RCT
by Hill et al20 or including the RCT by Lidwell1 et al.
Strategy T6 remained dominant with the highest prob-
ability (63% and 83%, respectively) and highest median
rank of being the most effective strategy (the details of
the sensitivity analyses are shown in online supplemen-
tary appendix 18).
DISCUSSION
Laminar airﬂow has been widely used as an important
infection control measure in many countries around the
world. In the UK, for instance, around 98% of all hip
arthroplasties are carried out in operating theatres
equipped with laminar airﬂow systems.30 The current
infection control guidelines in the UK31 and the USA32
recommend the use of laminar airﬂow to reduce
THR-related SSIs. It is an expensive technology, costing
US$60 000–US$90 000 for construction and installation
for each operating room.33 However, our study showed
that conventional ventilation together with systemic anti-
biotics and antibiotic-impregnated cement was most
likely to provide the best protection against THR-related
SSIs. We found no convincing evidence in favour of the
use of laminar airﬂow over conventional ventilation for
prevention of THR-related SSIs.
Although the point estimate for the infection control
strategy T3 (no systemic antibiotics+plain cement
+laminar airﬂow) compared with the referent was statis-
tically signiﬁcant, caution needs to be taken in its inter-
pretation because it had only one RCT conducted
between 1975 and 1978 by Hills and colleagues, and the
study reported that about 8% of the patients (99 in the
placebo group and 70 in the antibiotic group) did not
follow the RCT trial protocol with unreported use of
antibiotics. We therefore conducted a sensitivity analysis
by excluding this RCT from the MTC network and the
results for other strategies changed little, with T6
remaining the most effective.
A recent systematic review concluded that laminar
airﬂow tended to lower infection rates as opposed to
conventional ventilation, but the authors emphasised
that it was difﬁcult to draw a deﬁnite conclusion due to
confounding.8 The systematic review was descriptive,
involving no statistical analysis. It cited, among others,
the RCT by Lidwell et al1 as the key evidence for redu-
cing wound infection using laminar airﬂow. However,
this RCT did not control for antibiotics as a signiﬁcant
confounder. Our sensitivity analysis found that the
overall results changed little with the inclusion of this
RCT, so it had little inﬂuence on our conclusions.
Contrary to the key early evidence in the late 1960s to
early 1980s that laminar airﬂow and body exhaust suit
reduced wound contamination and SSIs,1 34 a number
Figure 3 The forest plot of ORs of infection control
strategies (random effect model).
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of subsequent studies in the 1980s and 1990s found no
convincing evidence that laminar airﬂow was effective in
reducing SSIs compared with conventional ventila-
tion.23 26 27 Four recent large-scale observational studies
of 113 183 THRs suggested that laminar airﬂow and
body exhaust suit conferred no protective beneﬁt
against SSI and might increase the risk of SSI.2 3 28 29
A hypothesis of the early studies by Charnley34 and
Lidwell et al1 on laminar airﬂow and body exhaust suits
was that one of the main routes of wound contamination
and infection was the air in the operating room, and
laminar airﬂow and body exhaust suits could reduce air-
borne bacteria load and therefore wound contamination
and infection. The studies demonstrated that laminar
airﬂow ventilation reduced airborne organisms or
colony forming units (cfu) to 10 cfu/m3 between 150
and 300 cfu/m3 in conventional operating theatres. To
be most effective, key operating theatre staff should wear
body exhaust suits while working in the ultraclean envir-
onment.1 34 However, standard culture techniques by air
sampling or landing ‘mode’ as a method to assess poten-
tial wound contamination do not directly correlate with
wound contamination, and they are at best surrogate
measures representing the degree of air contamination
at the point of sampling, which might be some distance
away from the implant zone.35 There was also evidence
that wound contamination was greater at the end of
surgery than at the beginning.35
The surgeons’ heads position above the surgical site
and directly in the laminar airstream might facilitate
pathogen-contaminating particles falling directly into
the wound.36 Laminar airﬂow could also result in lower
intraoperative tissue temperatures in the surgical
wound,3 and systemic hypothermia is a known risk factor
for SSI.37
Our study found no high-quality evidence that
antibiotic-impregnated cement without systemic anti-
biotic prophylaxis was effective in reducing THR-related
SSI compared with plain cement with systemic antibiotic
prophylaxis. Contrary to our ﬁndings, a recent
meta-analysis showed that the use of antibiotic-
impregnated cement lowered the infection rate by
approximately 50% compared with plain cement.6
However, the meta-analysis failed to stratify the infection
control arms according to antibiotic regimens and pool
on a comparable basis. We reanalysed the data from this
meta-analysis by stratifying infection control arms based
on antibiotic regimens and pooling the rest of the studies
on a comparable basis for summary estimation (see
online supplementary appendix 19). The pooled relative
risk of antibiotic-impregnated cement compared with
plain cement was 0.76 (95% CI 0.46 to 1.28). So there
was no high-quality evidence that antibiotic-impregnated
cement without systemic antibiotic prophylaxis was effect-
ive in reducing THR-related infection compared with
plain cement with systemic antibiotic prophylaxis.
A RCT showed that antibiotic-impregnated cement
together with systemic antibiotic prophylaxis was
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effective in reducing knee replacement-related infection
compared with plain cement with systemic antibiotic
prophylaxis.38 All the procedures were performed in a
standard operating room without laminar airﬂow or
body-exhaust suit. The authors stressed that while they
did not believe that antibiotic-impregnated cement
alone would prevent deep infection, it could aid in pre-
vention of early or intermediate infection in conjunction
with systemic antibiotic prophylaxis. This might be
explained by the capacity of antibiotic-impregnated
cement as a drug-delivery vehicle. It was suggested that
the polymeric nature of polymethylmethacrylate allowed
ingress of physiological ﬂuids, which permitted elution
of incorporated antibiotic, but the relative hydrophobi-
city of bone cement allowed only 10% of the antibiotic
to elute effectively.39
Our evidence synthesis has limitations. The small
number of studies available for evidence synthesis
reduced the statistical power and resulted in wide CrIs
for some comparisons. MTC can only synthesise evi-
dence in a connected network. Consequently, one
study40 meeting our inclusion criteria could not be
included as it could not be connected to the network.
However, the exclusion of this study should not change
our results, as the study concluded that there was no stat-
istical difference in THR-related SSIs between plain
cement and antibiotic-impregnated cement, which
accorded with our ﬁndings.
Owing to the limited data available, the MTC model
was unable to adjust for potential confounders such as
case-mix, particularly patient comorbidity in different
hospital settings, different types of laminar airﬂow
systems used (eg, horizontal vs vertical laminar airﬂow
systems), and temporal changes in clinical practices,
infection control technology (eg, the use of ultra-high
ﬂows in modern conventional operating theatres and
forced air blankets) and patient proﬁles which may have
taken place over the past several decades.
The evidence in our study covered a period from 1966
up to June 2011 when the literature search was per-
formed. The evidence needs to be updated when new
studies become available.
CONCLUSIONS
This is the ﬁrst study to examine the comparative effect-
iveness of various infection control strategies involving
multiple infection control measures in preventing
THR-related SSI. We found no convincing evidence in
favour of the use of laminar airﬂow over conventional
ventilation for prevention of THR-related SSI. Systemic
antibiotic prophylaxis in conjunction with antibiotic-
impregnated cement and conventional ventilation was
likely to be the most effective infection control strategy
for preventing THR-related SSI based on the available
evidence. There was no high-quality evidence that
antibiotic-impregnated cement alone without systemic
antibiotic prophylaxis was effective in reducing
THR-related SSI compared with plain cement with sys-
temic antibiotics. Our evidence synthesis underscores the
need to review current guidelines based on the available
evidence, and to conduct further high-quality double-
blind RCTs to better inform the current clinical guide-
lines and practice for prevention of THR-related SSI.
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